Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 642041, 11 pages
http://dx.doi.org/10.1155/2015/642041
Research Article

Potential Therapeutic Benefit of Combining Gefitinib and Tamoxifen for Treating Advanced Lung Adenocarcinoma

1Sex Hormone Research Center, Graduate Institute of Clinical Medical Science, School of Medicine, China Medical University, 6 Xueshi Rd., North District, Taichung 40403, Taiwan
2Department of Chest Medicine, Taichung Tzuchi Hospital, The Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan
3Department of Pathology, Taichung Tzuchi Hospital, The Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan
4Center of Molecular Medicine, China Medical University Hospital, Taichung, Taiwan
5Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan

Received 29 August 2014; Revised 25 December 2014; Accepted 25 December 2014

Academic Editor: Noriyoshi Sawabata

Copyright © 2015 Chien-Ming Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Chien-Ming Liu, Kuo-Liang Chiu, Tzu-Sheng Chen, et al., “Potential Therapeutic Benefit of Combining Gefitinib and Tamoxifen for Treating Advanced Lung Adenocarcinoma,” BioMed Research International, vol. 2015, Article ID 642041, 11 pages, 2015. doi:10.1155/2015/642041